Skip to Content

Logo (Actavis) 638 (Lamotrigine Extended-Release 250 mg)

Pill with imprint Logo (Actavis) 638 is Yellow, Capsule-shape and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Actavis Pharma, Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 638

Lamotrigine extended-release 250 mg Logo (Actavis) 638

Lamotrigine Extended-Release

Imprint
Logo (Actavis) 638
Strength
250 mg
Color
Yellow
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-1638
Inactive Ingredients
hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol 400, silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate, ferric oxide yellow, ferric oxide red, polydextrose, copovidone, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.